← All stocks

SUPERNUS PHARMACEUTICALS, INC.

SUPN Net selling

CIK 0001356576 #1815 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$19.67M

$3.03M on a plan · $15.25M straight out of an exercise

Sold at will

$1.38M

5 of 30 sales

Net

−$19.67M

−$1.38M against sales at will

By person

11 insiders · 33 transactions

107×

Jack A. Khattar holds 107 times base salary in stock. $111.89M of shares against $1.04M in salary for 2025.

Salary from the company's own proxy. The shares are what Jack A. Khattar last reported holding, valued at $50.48, the price Common Stock was last bought or sold at on the open market here, on 18 Mar 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Khattar Jack A.

President, CEO

—

$9.89M (11) scheduled

−$9.89M

2,216,451

3.81%

$111.89M

+13.7%

Bhatt Padmanabh P.

Sr. VP of IP, CSO

—

$5.42M (7) scheduled

−$5.42M

18,637

0.0321%

$940.80K

+67.3%

NEWHALL CHARLES W III

Director

—

$1.27M (2) scheduled

−$1.27M

124,119

0.2135%

$6.27M

+2.6%

Mottola Frank

SVP, Chief Tech. Ops. Officer

—

$1.10M (3) scheduled

−$1.10M

19,544

0.0336%

$986.58K

+110.7%

GEMAYEL GEORGES

Director

—

$1.00M (2)

−$1.00M

27,277

0.0469%

$1.38M

+104.9%

Horich William Todd

SVP, Commercial Operations

—

$483.80K (2)

−$483.80K

0.0000%

$0.00

−100.0%

Hudson Frederick M.

Director

—

$271.73K (1)

−$271.73K

60,413

0.1039%

$3.05M

+62.8%

Sensenig Bethany

Director

—

$228.26K (2) scheduled

−$228.26K

0.0000%

$0.00

—

Barlow Carrolee

Director

—

27,045

0.0465%

$1.37M

+57.2%

Rubin Jonathan

SVP, Chief Medical Officer

—

13,979

0.0240%

$705.66K

+123.8%

DEC TIMOTHY C

Senior Vice-President & CFO

—

9,129

0.0157%

$460.83K

+0.6%

Individual transactions

Insider

Date

Role

Action

Price

Amount

GEMAYEL GEORGES

23 Feb 2026

Director

Exercised, kept

15,000

$12.98

$194.70K

Hudson Frederick M.

9 Jan 2026

Director

Exercised, kept

15,000

$12.98

$194.70K

NEWHALL CHARLES W III

21 Nov 2025

Director

Exercised, kept

15,000

$12.98

$194.70K

Show all 33 transactions →

What was left out

Form 4 filings counted 59

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 5

Sales straight out of an exercise 20

Sales at will 5

Transactions with no price 0

Shares from compensation/vesting 687,738

History held since 16 Sep 2016